BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20826493)

  • 21. Paediatric cancer pain management using the WHO analgesic ladder--results of a prospective analysis from 2265 treatment days during a quality improvement study.
    Zernikow B; Smale H; Michel E; Hasan C; Jorch N; Andler W
    Eur J Pain; 2006 Oct; 10(7):587-95. PubMed ID: 16243549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing methadone, a unique analgesic.
    Manfredi PL; Houde RW
    J Support Oncol; 2003; 1(3):216-20. PubMed ID: 15334878
    [No Abstract]   [Full Text] [Related]  

  • 24. Opioid rotation from methadone: fraught with difficulties.
    Bhimji K
    J Pain Symptom Manage; 2005 Apr; 29(4):334-5. PubMed ID: 15857735
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid switching between transdermal fentanyl and methadone in cancer patients.
    Mercadante S; Ferrera P; Villari P; Casuccio A
    J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical guide to opioids and their complications in managing cancer pain. What oncologists need to know.
    Davis MP; Lasheen W; Gamier P
    Oncology (Williston Park); 2007 Sep; 21(10):1229-38; discussion 1238-46, 1249. PubMed ID: 17926800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary.
    Dunteman ED
    J Pain Palliat Care Pharmacother; 2005; 19(1):35-43. PubMed ID: 15814513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methadone in the treatment of chronic non-malignant pain].
    Bendiksen A; McGehee E; Handberg G
    Ugeskr Laeger; 2007 Apr; 169(17):1568-72. PubMed ID: 17484827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The experience of chronic severe pain in patients undergoing methadone maintenance treatment.
    Karasz A; Zallman L; Berg K; Gourevitch M; Selwyn P; Arnsten JH
    J Pain Symptom Manage; 2004 Nov; 28(5):517-25. PubMed ID: 15504628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to methadone maintenance treatment of opiate dependent patients with and without significant pain.
    Ilgen MA; Trafton JA; Humphreys K
    Drug Alcohol Depend; 2006 May; 82(3):187-93. PubMed ID: 16219429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
    Mercadante S
    Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analgesic effect of paracetamol on cancer related pain in concurrent strong opioid therapy. A prospective clinical study.
    Axelsson B; Stellborn P; Ström G
    Acta Oncol; 2008; 47(5):891-5. PubMed ID: 17965980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low morphine doses in opioid-naive cancer patients with pain.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Ficorella C; Verna L; Tirelli W; Villari P; Arcuri E
    J Pain Symptom Manage; 2006 Mar; 31(3):242-7. PubMed ID: 16563318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone treatment for pain states.
    Toombs JD; Kral LA
    Am Fam Physician; 2005 Apr; 71(7):1353-8. PubMed ID: 15832538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of methadone maintenance treatment patients prescribed opioid analgesics.
    Glenn MC; Sohler NL; Starrels JL; Maradiaga J; Jost JJ; Arnsten JH; Cunningham CO
    Subst Abus; 2016; 37(3):387-391. PubMed ID: 26731299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.